Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

CDSCO Flags Besto-Cof Cough Syrup as Spurious, Raipur Drug Lab Claims Batch Not Made by Listed Firm

Susmita Roy25 Oct 2025 4:25 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a warning after the State Drug Testing Laboratory (SDTL) in Raipur,...

Sun Pharma Gets CDSCO Panel Approval to Conduct Phase III Study of Oral Semaglutide

Susmita Roy25 Oct 2025 4:13 PM IST

New Delhi: Pharmaceutical major Sun Pharma Laboratories has got the go ahead from the Subject Expert Committee (SEC) functional under the Central...

CDSCO Ends Emergency-Use Authorization of Baricitinib for COVID-19 Treatment

Susmita Roy25 Oct 2025 3:35 PM IST

New Delhi: In a recent regulatory update, the Central Drugs Standard Control Organisation (CDSCO) has formally approved the withdrawal of COVID-19...

CDSCO Flags 112 Drug Batches Including Telmisartan, Pantoprazole, Cefixime, Glimepiride as Not of Standard Quality

Susmita Roy25 Oct 2025 1:53 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has identified 112 batches of medicines and medical products as "Not of Standard...

Health Ministry Proposes Barcoding Rule for All Vaccines, Antimicrobials, Anticancer, and Narcotic Drugs

Susmita Roy23 Oct 2025 2:55 PM IST

New Delhi: In a major regulatory move, the Ministry of Health and Family Welfare (MoHFW) has proposed amendments to the Drugs Rules, 1945, to include...

Torrent Pharma Receives SEC Approval to Market Alogliptin-Metformin FDC, Asked to Conduct Phase IV Trial

Susmita Roy23 Oct 2025 1:44 PM IST

New Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted approval to...

CDSCO Panel Seeks More Toxicity Data from Macleods on Semaglutide Injection Pre-Filled Pens

Susmita Roy23 Oct 2025 1:28 PM IST

New Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organization (CDSCO), has opined that Macleods...

High-Alcohol Oral Drugs Over 12% to Come Under Prescription-Only H1 Category, Health Ministry Drafts Rules

Susmita Roy22 Oct 2025 9:36 PM IST

New Delhi: With an aim to curb misuse and over-the-counter sale of high-alcohol oral preparations, through a recent Gazette notification, the Ministry...

Biocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal Deaths

Susmita Roy21 Oct 2025 1:00 PM IST

New Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined that Biocon...

Doctors Slam FSSAI Inaction After Delhi HC Allows ORSL Sales, Warn of Child Health Risks

Alkem Vs Alchem: Delhi HC Grants Interim Relief to Alkem Labs in Trademark Tussle

Susmita Roy21 Oct 2025 12:55 PM IST

New Delhi: In a major trademark dispute between two prominent names in the pharmaceutical and nutraceutical industry, the Delhi High Court has granted...

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India

Susmita Roy21 Oct 2025 12:30 PM IST

New Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted permission to...

CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis

Susmita Roy20 Oct 2025 5:44 PM IST

New Delhi: Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the Subject Expert...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok